申请人:SmithKline & French Laboratories Limited
公开号:US04159329A1
公开(公告)日:1979-06-26
The compounds are substituted isocytosines which are histamine H.sub.2 -antagonists. Two specific compounds of the present invention are 2-[2-(5-methyl-4-imidazolylmethylthio)-ethylamino]-5-(3-methoxybenzyl)-4-p yrimidone and 2-[2-(5-methyl-4-imidazolylmethylthio)ethylamino]-6-benzyloxy-4-pyrimidone .
这些化合物是取代的异
胞嘧啶,它们是
组胺H.sub.2-
拮抗剂。本发明的两种具体化合物是2-[2-(5-
甲基-4-
咪唑基甲
硫基)-乙基
氨基]-5-(3-
甲氧基苯基)-4-
嘧啶酮和2-[2-(5-
甲基-4-
咪唑基甲
硫基)乙基
氨基]-6-苄
氧基-4-
嘧啶酮。